Home›Companies›Biotech & Pharma›Vertical Longevity Pharma

Vertical Longevity Pharmaceuticals, Inc.

Developing a vaccine intended to treat people with clogged arteries.

Updated Nov 9, 2026·Latest SEC filing Sep 28, 2026·Suggest an edit

About Vertical Longevity Pharma

Vertical Longevity Pharma is a private company based in Irvine, California, incorporated in 2024 in Delaware. It has reported $110,000 raised in one offering on Form D since September 2026. Its chief executive is David Scieszka.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 4, 2025Sep 28, 2026$110,000fully sold5$22,000Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Vertical Longevity Pharma's Form D filed Sep 28, 2026.

Sources

  1. SECVertical Longevity Pharmaceuticals, Inc. filing history
  2. CompanyVertical Longevity Pharma offering
  3. InvestorVertical Longevity Pharma portfolio profile
  4. ResearchVertical Longevity Pharma on NetCapital